You are here: Home » News-IANS » Health-Medicine
Business Standard

Osteoporosis drug may help reduce heart diseases

IANS  |  Hong Kong 

A commonly used drug for treating or bone may also help reduce the risk of death by cardiovascular, and stroke, according to a study.

The report, published in Journal of Bone and Mineral Research, showed that the drug Alendronate could lower the risk of by 67 per cent and by 45 per cent within a year.

Intake of the drug also reduced the risk of by 18 per cent within five years and 17 per cent within 10 years.

"Our findings show that Alendronate is potentially cardioprotective in hip fracture patients," said Ching-Lung Cheung, from the

"Physicians should consider prescribing Alendronate or other similar drugs to patients with hip fracture and patients should also have good compliance with Alendronate treatment, as this is not only good for your bones but also your heart," Cheung added.

Alendronate belongs to a class of drugs called bisphosphonates and works by preventing bone breakdown and increasing bone density.

It is used for osteoporosis, osteogenesis imperfecta, and

The researchers collected data from 34,991 patients, diagnosed with hip fracture in 2005. Out of these 4,602 patients received treatment during follow up.

Due to excess cardiovascular adverse events, there is a worldwide crisis in the current treatment of with drug romosozumab.

In 2017, the (FDA) had rejected romosozumab and requested more data before reaching a decision.

The study, thus, has significant implications in clinical trial design of anti-osteoporosis medications, the researchers said.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, May 12 2018. 15:40 IST